CACNG8

CACNG8 encodes TARP γ-8, a transmembrane AMPA receptor regulatory protein (TARP) that functions as an auxiliary subunit of AMPA receptors to control their trafficking, gating, and synaptic localization, particularly in hippocampal and prefrontal cortical circuits (PMID:26989142, PMID:34099816). TARP γ-8 physically associates with the AMPAR pore-forming subunit, and disruption of this interaction—by pharmacological modulators, loss-of-function mutations, or gene knockout—impairs AMPAR-mediated excitatory synaptic transmission in layer 2–3 prefrontal cortex pyramidal neurons and hippocampus (PMID:26989142, PMID:34099816, PMID:36031768). Knockout of CACNG8 in mice produces ADHD-like behavioral phenotypes including hyperactivity, impulsivity, and cognitive impairment, with synaptosomal proteomic evidence of disrupted glutamatergic and dopaminergic signaling that is rescued by methylphenidate (PMID:36031768). Rare human variants including stop-gain and missense mutations destabilize postsynaptic AMPAR complexes and disrupt binding to scaffolding proteins PSD-93, PSD-95, and CNIH2/3 (PMID:41127817).

1. 2016 High

   Establishing that TARP γ-8 is not merely an AMPAR-associated protein but is mechanistically required for receptor modulation resolved how auxiliary subunits control AMPAR pharmacology.

   Evidence Calcium flux, radioligand binding, and electrophysiology with wild-type and mutant TARP γ-8 showing that novel AMPAR modulators act by partially disrupting the TARP γ-8–AMPAR pore subunit interaction

   PMID:26989142

   Open questions at the time

   • Exact binding interface between TARP γ-8 and AMPAR subunit not structurally resolved
   • Whether other TARPs can substitute for γ-8 in this pharmacological mechanism not tested
2. 2021 High

   Demonstrating that reduced CACNG8 expression selectively impairs AMPAR-mediated transmission in prefrontal cortex layer 2–3 pyramidal neurons linked a transcription-level regulatory variant to a defined synaptic deficit.

   Evidence Electrophysiology in heterozygous/KO mouse prefrontal cortex slices combined with reporter gene assay showing a G-quadruplex-forming SNP (rs10420324G) suppresses CACNG8 transcription

   PMID:34099816

   Open questions at the time

   • Whether the G-quadruplex SNP affects CACNG8 expression in human neurons not shown
   • Cell-type specificity of TARP γ-8 dependency beyond layer 2–3 pyramidal neurons unclear
3. 2022 High

   Full knockout revealed that TARP γ-8 loss produces a composite behavioral phenotype (ADHD-like hyperactivity, impulsivity, cognitive impairment) driven by AMPAR complex dysfunction and dopaminergic/glutamatergic pathway dysregulation, establishing an in vivo systems-level role.

   Evidence TARP γ-8 knockout mouse behavioral battery, synaptosomal proteomics in hippocampus and prefrontal cortex, pharmacological rescue with methylphenidate

   PMID:36031768

   Open questions at the time

   • Whether conditional or region-specific knockout recapitulates the full behavioral syndrome not tested
   • Direct causality between proteomic changes and specific behavioral outputs not established
4. 2025 Medium

   Computational analysis of rare human CACNG8 variants predicted severe destabilization of postsynaptic AMPAR complexes and disrupted interactions with scaffolding partners, extending the loss-of-function mechanism to specific human mutations.

   Evidence Whole exome sequencing identifying stop-gain (p.Arg123Ter) and missense variants, followed by molecular docking, MM-PBSA/MM-GBSA, and molecular dynamics simulations of AMPAR–TARP γ-8–scaffold complexes

   PMID:41127817

   Open questions at the time

   • Computational predictions of destabilization have not been experimentally validated by binding assays or electrophysiology
   • Clinical phenotypes of individuals carrying these rare variants not fully characterized
   • Whether these variants act through haploinsufficiency or dominant-negative mechanisms is unknown

• A high-resolution experimental structure of the full TARP γ-8–AMPAR–scaffold ternary complex is needed to validate computational models and define the precise molecular interfaces disrupted by disease-associated mutations.
• No experimental atomic structure of the full TARP γ-8–AMPAR–PSD-95/CNIH ternary complex
• Mechanism by which TARP γ-8 loss differentially affects glutamatergic versus dopaminergic circuits is unresolved
• Whether CACNG8 variants contribute to human ADHD or other neurodevelopmental disorders through Mendelian or complex-trait mechanisms is undetermined